Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samar Ibrahim

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Health Policy (Amsterdam, Netherlands)|May 24, 2025
Lived experience of out-of-pocket costs of health care and medicines by people with chronic conditions and their families in Australia: a systematic review of the qualitative literatureJane Desborough, Charles Maskell-Knight, Shelley Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 18, 2026
NINJ1-Mediated Plasma Membrane Rupture in Lytic Cell Death: Mechanisms, Consequences, and ContextZeinab A El-Moaty, Rabab S Hamad, Mohamed A M Ali, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 16, 2025
Targeting inflammation-driven tumor progression with Zafirlukast via modulation of Jagged-1/Notch-1/Hes-1, Wnt-4/β-catenin, and VEGF signaling pathways in miceAsmaa Saleh, Dina F Mansour, Nahed A Raslan, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 11, 2025
Mechanistic insights into the hepatoprotective role of rabeprazole against cyclophosphamide-induced hepatotoxicity via AMPK/SIRT1 activation and suppression of TLR4/NF-κB and MAPK pathwaysAsmaa Saleh, Nahed A Raslan, Heba Mohammed Refat M Selim, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosisDalia H El-Kashef, Mahmoud E Youssef, Mohamed Nasr, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 10, 2022
Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitisSimona Cavalu, Hossam Sharaf, Sameh Saber, et al.
Frontiers in Pharmacology|June 27, 2022
Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative ColitisAmir Mohamed Abdelhamid, Mahmoud E Youssef, Simona Cavalu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Health Policy (Amsterdam, Netherlands)|May 24, 2025
Lived experience of out-of-pocket costs of health care and medicines by people with chronic conditions and their families in Australia: a systematic review of the qualitative literatureJane Desborough, Charles Maskell-Knight, Shelley Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 18, 2026
NINJ1-Mediated Plasma Membrane Rupture in Lytic Cell Death: Mechanisms, Consequences, and ContextZeinab A El-Moaty, Rabab S Hamad, Mohamed A M Ali, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 16, 2025
Targeting inflammation-driven tumor progression with Zafirlukast via modulation of Jagged-1/Notch-1/Hes-1, Wnt-4/β-catenin, and VEGF signaling pathways in miceAsmaa Saleh, Dina F Mansour, Nahed A Raslan, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 11, 2025
Mechanistic insights into the hepatoprotective role of rabeprazole against cyclophosphamide-induced hepatotoxicity via AMPK/SIRT1 activation and suppression of TLR4/NF-κB and MAPK pathwaysAsmaa Saleh, Nahed A Raslan, Heba Mohammed Refat M Selim, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosisDalia H El-Kashef, Mahmoud E Youssef, Mohamed Nasr, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 10, 2022
Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitisSimona Cavalu, Hossam Sharaf, Sameh Saber, et al.
Frontiers in Pharmacology|June 27, 2022
Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative ColitisAmir Mohamed Abdelhamid, Mahmoud E Youssef, Simona Cavalu, et al.
Pageof 3